Zacks: Brokerages Expect Homology Medicines, Inc. (NASDAQ:FIXX) Will Announce Quarterly Sales of $1.05 Million

Analysts expect Homology Medicines, Inc. (NASDAQ:FIXX – Get Rating) to report sales of $1.05 million for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Homology Medicines’ earnings, with the highest sales estimate coming in at $1.30 million and the lowest estimate coming in at $800,000.00. Homology Medicines posted sales […]

Related Keywords

Virginia ,United States ,Blackrock , ,Caxton Associates ,Goldman Sachs Group Inc ,Credit Suisse Group ,Zacks Investment Research ,Blackrock Inc ,Nasdaq ,Franklin Resources Inc ,Homology Medicines Company Profile Get Rating ,Homology Medicines Inc ,Homology Medicines ,Get Rating ,Zacks Investment ,Homology Medicine ,Suisse Group ,Retirement Systems ,Sachs Group ,Medicines Company Profile ,Nasdaq Fixx ,Fixx ,Medical ,Ratings ,Consensus ,